3052 ORCHARD DRIVE, SAN JOSE, CA
Reports Fourth Quarter and Full Year 2025 Financial Results
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned
Investor Presentation
Financial Results, Press Release
Appoints Renee Gaeta as Chief Financial Officer
Appoints Industry Veteran Kevin O’Boyle to its Board of Directors
FY 2024
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Amended Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Specialized Disclosure Report